1. Introduction {#sec1-ijms-21-01788}
===============

The *meso*-diaminopimelate dehydrogenase (*meso-*DAPDH) from *Symbiobacterium thermophilum* IAM14863 (StDAPDH) was the first *meso*-DAPDH reported to catalyze the asymmetric amination of 2-keto acids, with consequent D-amino acid production \[[@B1-ijms-21-01788]\]. D-amino acids are used in the pharmaceutical industry, foods, and cosmetics \[[@B2-ijms-21-01788],[@B3-ijms-21-01788]\]. Among the different D-amino acid bioproduction methods, asymmetric amination with 2-keto acids as starting materials has several advantages, such as a one-step reaction, a theoretical yield of 100%, and environmental safety \[[@B2-ijms-21-01788]\]. For instance, Akita et al. established an efficient system using the *meso*-DAPDH from *Ureibacillus thermophaericus* strain A1 (UtDAPDH) to produce D-branched-chain amino acids with a yield and optical purity \> 99% \[[@B4-ijms-21-01788]\].

The utilization of thermostable enzymes can decrease the cost of process control and the risk of contamination, and increase the solubility of the substrate and the reaction rates \[[@B5-ijms-21-01788],[@B6-ijms-21-01788]\]. Therefore, thermostable enzymes are of interest for industrial applications. Recently, Akita et al. focused on the screening of more stable *meso*-DAPDHs for industrial production of D-amino acids. Finally, UtDAPDH was found to be stable after incubation for 30 min at 60 °C \[[@B7-ijms-21-01788]\]. Divergent evolution has been found in the *meso*-DAPDH family \[[@B8-ijms-21-01788]\]. All members of the type II group, which is represented by StDAPDH, show obvious catalytic activity with 2-keto acids. UtDAPDH belongs to type I. Five substitutions were introduced into UtDAPDH in order to create its ability to catalyze 2-keto acids \[[@B9-ijms-21-01788],[@B10-ijms-21-01788]\]. As reported, StDAPDH is currently the most thermostable member of both groups. *S. thermophilum* is a syntrophic bacterium and its growth is dependent on co-culture with *Bacillus* \[[@B11-ijms-21-01788],[@B12-ijms-21-01788],[@B13-ijms-21-01788]\]. The optimal culture temperature of strain T is 60 °C \[[@B11-ijms-21-01788]\], which may explain why StDAPDH from the original strain can maintain 94% activity when incubated at 70 °C for 1 h \[[@B1-ijms-21-01788]\]. The combination of its substrate spectrum and thermostability indicate that StDAPDH has great potential in future enzyme engineering and industrial applications \[[@B1-ijms-21-01788]\].

In nature, *meso*-DAPDHs catalyze the reversible oxidative deamination of *meso*-2,6-diaminopimelate (*meso*-DAP), which is an NADP^+^-dependent process \[[@B1-ijms-21-01788],[@B14-ijms-21-01788],[@B15-ijms-21-01788],[@B16-ijms-21-01788]\]. The sole structural difference between NAD(H) and NADP(H) is an additional phosphate group at the 2'-hydroxyl group of the adenosine monophosphate (AMP) moiety of NADP(H) ([Figure 1](#ijms-21-01788-f001){ref-type="fig"}). However, compared to NADP^+^/NADPH, NAD^+^/NADH has some advantages in industrial applications. Firstly, NADH is less expensive than NADPH \[[@B17-ijms-21-01788],[@B18-ijms-21-01788],[@B19-ijms-21-01788]\]. The cost of NADH is USD 126/g, while the cost of NADPH is USD 1330/g (Sigma-Aldrich, 2020 catalog). Therefore, various oxidoreductase reactions have been performed to develop regeneration systems for NAD(P)(H) \[[@B20-ijms-21-01788],[@B21-ijms-21-01788],[@B22-ijms-21-01788]\]. For example, glucose dehydrogenase has been coupled for the synthesis of D-amino acids by *meso*-DAPDHs \[[@B4-ijms-21-01788],[@B23-ijms-21-01788]\]. Secondly, NADH is more stable than NADPH \[[@B19-ijms-21-01788],[@B24-ijms-21-01788],[@B25-ijms-21-01788]\]. Therefore, cofactor engineering, for enzymes such as alcohol dehydrogenase and xylose reductase, has been of great interest to various research groups \[[@B5-ijms-21-01788],[@B26-ijms-21-01788],[@B27-ijms-21-01788],[@B28-ijms-21-01788]\]. The seminal work on cofactor engineering was completed by Scrutton et al. in 1990, in which, Arg198 and Arg204 were determined to be crucial to the cofactor specificity of glutathione reductase and mutations with a marked preference for NAD^+^ were obtained \[[@B29-ijms-21-01788]\]. However, there is little research reported on the cofactor engineering of *meso*-DAPDHs.

In the present study, residue K159 was found to be the key residue for the cofactor specificity of StDAPDH. Molecular dynamics (MD) simulations were performed to investigate the underlying molecular mechanisms.

2. Results and Discussion {#sec2-ijms-21-01788}
=========================

2.1. Selection of Mutations {#sec2dot1-ijms-21-01788}
---------------------------

Divergent evolution has been reported in the *meso*-DAPDH family \[[@B8-ijms-21-01788]\]. Amino acid residues V14, V68, P69, T70, S90, V156, and K159 of StDAPDH have been reported in our previous study \[[@B30-ijms-21-01788]\]. These residues were predicted as NADP^+^-binding residues and are highly conserved during the evolution of type II *meso*-DAPDHs, but they differ from the residues in type I *meso*-DAPDHs. In the representative member of the type I group, *meso*-DAPDH from *Corynebacterium glutamicum* ATCC13032, the allelic NADP^+^-binding residues are L14, M66, G67, S68, T88, D154, and R157. Therefore, V14L, V68M, P69G, T70S, S90T, V156D, and K159R mutant proteins were constructed to investigate the roles of these residues during catalysis by StDAPDH. Since these seven residues are highly conserved NADP^+^-binding sites, we wanted to determine whether they were responsible for cofactor specificity.

It has been reported that during catalysis by StDAPDH, H154 assists a water molecule to attract the amino acid intermediate, which is formed by hydride transfer from the Cα of *meso*-DAP to the C4N of the nicotinamide ring of NADP^+^ \[[@B30-ijms-21-01788]\]. This indicates that the orientation of the nicotinamide ring of NADP^+^ plays a key role in catalysis by *meso*-DAPDH. Although the adenosine ring is distal from the enzyme's catalytic center, it is thought to have an enormous influence on enzyme activity, including kinetics and substrate specificity \[[@B31-ijms-21-01788],[@B32-ijms-21-01788],[@B33-ijms-21-01788]\]. There have been several cofactor engineering studies focused on the residues around the AMP moiety \[[@B5-ijms-21-01788],[@B34-ijms-21-01788],[@B35-ijms-21-01788]\]. [Figure 2](#ijms-21-01788-f002){ref-type="fig"} shows the polar contacts between NADP^+^ and the seven residues in StDAPDH (PDB ID: 3wbf \[[@B36-ijms-21-01788]\]). Among these polar contacts, there was only one H-bond interaction between V156 and K159. V14 and K159, which showed polar contacts with the AMP moiety, were selected for subsequent experiments.

2.2. Determination of Kinetic Parameters with NADH as Cofactor. {#sec2dot2-ijms-21-01788}
---------------------------------------------------------------

After the preparation of wild-type and mutant proteins, NADH was chosen as the cofactor to determine the kinetic parameters for pyruvic acid. As shown in [Table 1](#ijms-21-01788-t001){ref-type="table"}, when NADH was used, the wild-type enzyme and the V14L mutant showed no catalytic activity with regard to pyruvic acid, which indicated that they were essentially specific for NADPH. By contrast, K159R was not entirely NADPH specific. The apparent K~M~ value of K159R with pyruvic acid, with NADH as the cofactor, was approximately the same as the K~M~ values of the wild-type enzyme and K159R, with NADPH as the cofactor. Therefore, this mutation resulted in an increased affinity for pyruvic acid, with NADH as the cofactor. The k~cat~/K~M~ ratio of K159R with pyruvic acid was higher than that of wild-type with NADH as the cofactor. These results suggested that K159 was a major determinant of the cofactor specificity of StDAPDH. However, the overall efficiency of K159R was significantly lower than that of the wild-type enzyme with NADPH as the cofactor, mainly due to the low turnover number (*k*~cat~).

2.3. MD Simulation Analysis {#sec2dot3-ijms-21-01788}
---------------------------

To elucidate the molecular determinants of K159R on cofactor specificity, MD simulations of the protein-NADH complexes, including the native and K159R mutant proteins were performed for 100 ns.

### 2.3.1. Root Mean Square Deviation Analysis {#sec2dot3dot1-ijms-21-01788}

Root mean square deviation (RMSD) analyses of the proteins and NADH are shown in [Figure 3](#ijms-21-01788-f003){ref-type="fig"}. The backbone of both wild-type and K159R proteins achieved a stable conformation at 20 ns and remained stable until 100 ns ([Figure 3](#ijms-21-01788-f003){ref-type="fig"}a). This indicates that the binding of NADH did not cause major changes in the structure of the enzyme. These trajectories were utilized for the further analysis.

For NADH ([Figure 3](#ijms-21-01788-f003){ref-type="fig"}b), whether combined with the wild-type or mutant enzyme, the Cα atom of NADH achieved stability at 20 ns and remained stable until 40 ns. After that, NADH bound to the wild-type enzyme showed a higher RMSD deviation compared to NADH bound to K159R, especially between 50 and 90 ns. NADH binding to K159R was stable from 20 ns, but at 90 ns, it showed some deviation. These results suggested that, compared to K159R, the wild-type enzyme was less able to form stable conformations with NADH.

### 2.3.2. Root Mean Square Fluctuation Analysis {#sec2dot3dot2-ijms-21-01788}

In order to evaluate the plasticity of each residue of the wild-type and K159R enzymes, the root mean square fluctuation (RMSF) of the protein Cα atom was analyzed with respect to the starting structures. As shown in [Figure 4](#ijms-21-01788-f004){ref-type="fig"}a, the overall fluctuation of wild-type and mutant enzymes showed no significant differences. Residue 159 was significantly rigid in both systems. However, the K159R mutant showed higher rigidity in residues 35-39 (marked as "D1" in [Figure 4](#ijms-21-01788-f004){ref-type="fig"}), 123-146 (D2), and 243-259 (D3) and higher fluctuation in residues 175-178 (D4) and 237-241 (D5). According to the alignment of *meso*-DAPDH structures, residues 35-39 formed a loop between α2 and β2 and was located in the dinucleotide-binding domain. Residues 237-241, 123-146, and 243-259 formed loops between β12 and β13, the β-sheet β7, and β13, respectively, and were located in the polymerization domain. Residues 175-178 formed helix α10, located in the C-terminal domain \[[@B37-ijms-21-01788]\]. For *meso*-DAPDHs, the C-terminal domain was responsible for substrate binding, while the N-terminal domain was involved in nucleotide binding \[[@B38-ijms-21-01788]\]. As shown in [Figure 4](#ijms-21-01788-f004){ref-type="fig"}b, amino acid residues around the substrate-binding pocket showed obvious changes in flexibility, which indicated that the mutation of position 159 may reshape the active conformation of the enzyme for cofactor binding.

### 2.3.3. Conformational Analysis {#sec2dot3dot3-ijms-21-01788}

To determine whether the global change in structure improved the binding conformation of NADH, the conformations of NADH bound to wild-type and K159R mutant enzymes were compared.

As stated above, during MD simulations, NADH bound to the wild-type protein was less stable than NADH bound to the K159R mutant protein. Therefore, we first analyzed the orientation of NADH at 0 ns and 100 ns ([Figure 5](#ijms-21-01788-f005){ref-type="fig"}). At 0 ns, NADH showed almost the same conformation and was oriented in the substrate binding pocket in both the wild-type and mutant proteins. After 100 ns, the nicotinamide ring of NADH in the K159R mutant remained in a similar orientation ([Figure 5](#ijms-21-01788-f005){ref-type="fig"}b), but NADH in the wild-type protein was away from the catalytic site and subsequently, showed a conformational change ([Figure 5](#ijms-21-01788-f005){ref-type="fig"}a). During the first step of the catalytic process of *meso*-DAPDHs, the enzyme has an open conformation and binds NADP(H), without conformational changes. Subsequently, the substrate enters the binding pocket and the enzyme closes \[[@B38-ijms-21-01788]\]. Therefore, the wild-type enzyme cannot bind NAD(H) following the binding of the substrate, but the K159R mutant can do so. This was in agreement with the results of the RMSD analysis of NADH.

Secondly, for the final conformation of the K159R mutant enzyme, interactions between NADH and residues within 5Å were analyzed to understand the molecular mechanisms. As shown in [Figure 6](#ijms-21-01788-f006){ref-type="fig"}, when lysine at position 159 was mutated to arginine, a salt bridge formed between R159 and atom O2A of the AMP moiety of NADH. Moreover, 15 hydrogen bond interactions were found between NADH and residues of the K159R mutant. As shown in our previous study, arginine was more easily able to form a salt bridge interaction than lysine \[[@B30-ijms-21-01788]\]. In conclusion, the likely mechanism may be that, the larger steric hindrance of arginine compared to lysine and the formation of a salt bridge stabilized the active conformation of the enzyme when NADH was used as the cofactor.

Overall, in this study, we identified the key role of the amino acid residue at position 159 in determining the cofactor specificity of thermostable StDAPDH. The K159R mutant was found to have equal affinity to pyruvic acid with NADH or NADPH as the cofactor. However, the catalytic efficiency was still too low for industrial applications. Future research should focus on improving catalytic performance and further broadening the substrate spectrum with NADH as the cofactor.

3. Materials and Methods {#sec3-ijms-21-01788}
========================

3.1. Materials and Strains {#sec3dot1-ijms-21-01788}
--------------------------

NADH was purchased from Sigma-Aldrich (St Louis, MO, USA). Pyruvic aid and NH~4~Cl were purchased from Sinopharm Chemical Reagent Beijing Co. Ltd. (Beijing, China). The protein purification kit was purchased from Beaver Bioscience (Suzhou, China). Reagents for molecular biology were purchased from Sangon Biotech Co., Ltd. (Shanghai, China).

The K159R mutant was constructed in our previous study \[[@B30-ijms-21-01788]\] following the protocol of whole-plasmid polymerase chain reaction in \[[@B8-ijms-21-01788]\]. The bacterial strains producing wild-type and K159R mutant StDAPDH were maintained in our lab.

3.2. Overexpression and Purification of Proteins {#sec3dot2-ijms-21-01788}
------------------------------------------------

Both wild-type and K159R mutant proteins were overexpressed in *Escherichia coli* BL21(DE3)plys using a previously published protocol \[[@B1-ijms-21-01788]\]. Cells were harvested by centrifugation and then disrupted by sonication (Scientz, Ningbo, China). Purified proteins were prepared by nickel chelate affinity chromatography using previously published protocols \[[@B8-ijms-21-01788]\], which was newly cited by reference \[[@B30-ijms-21-01788]\] and \[[@B39-ijms-21-01788]\].

3.3. Determination of Kinetic Constants {#sec3dot3-ijms-21-01788}
---------------------------------------

Initial reaction rates were determined by monitoring the decrease in absorbance at 340 nm, which corresponds to the consumption of NADH. Kinetic parameters were determined with the concentrations of pyruvic acid varied from 0.2 mM to 20 mM using previously described protocols \[[@B39-ijms-21-01788]\], except with NADH as the cofactor. Kinetic parameters were calculated by non-linear fitting the reaction rates versus concentrations of pyruvic acid \[[@B39-ijms-21-01788]\].

3.4. MD Simulations {#sec3dot4-ijms-21-01788}
-------------------

MD simulations were performed using the GROMACS2018.2 package \[[@B40-ijms-21-01788]\]. The chain A coordinates of wild-type StDAPDH (PDB ID: 3wbf) were used for the construction of the protein-NADH complex *in situ*.

The force fields Amberff99SB-ildn and gaff were applied to the protein structure and ligand, respectively \[[@B41-ijms-21-01788]\]. The complexes were immersed in a cubic box with sufficient distance between the protein and box edges and then solvated with a TIP39 water model using the "genbox" tool \[[@B42-ijms-21-01788]\]. Two Na^+^ were added to neutralize the system. Before equilibration, each complex was subjected to energy minimization using the steepest descent method with 10,000 steps \[[@B43-ijms-21-01788]\] and position-restrained MD simulation for 100 ps. Equilibrations, including constant number of particles, volume, and temperature (NVT) and constant number of particles, pressure, and temperature (NPT) were then performed. NVT and NPT steps were performed for 100 ps at 298.15 K and 1 bar to stabilize the temperature and pressure of the system. Finally, a 100 ns production MD with a 2 fs step was initiated to analyze the changes in the system. Coordinates were recorded every 20 ps to construct the trajectory. Long-range electrostatic interactions were evaluated using the particle mesh Ewald method.

3.5. Analysis of Molecular Dynamics Trajectories {#sec3dot5-ijms-21-01788}
------------------------------------------------

The RMSD and RMSF of the protein-NADH complex were analyzed using MD trajectories, with the built-in tools of the GROMACS package. RMSD and RMSF plots were constructed using Origin8.5 software. Visualization analyses were performed using PyMOL (<http://pymol.sourceforge.net/>).

4. Conclusions {#sec4-ijms-21-01788}
==============

StDAPDH, the *meso*-DAPDH from *S. thermophilum*, is the most thermostable DAPDH currently known. It is NADP^+^-dependent and shows catalytic activity with 2-keto acids. The present study reported the altered cofactor specificity of StDAPDH from NADPH to both NADH and NADPH by the replacement of K159 with arginine and proposed an underlying mechanism. Although K159 is highly conserved among type II *meso*-DAPDHs, these results indicated that conserved amino acid residues can be chosen as targets for cofactor engineering. Taken together, the results of this study give us a deeper understanding of the catalytic mechanism of StDAPDH and provide a starting point for the engineering of *meso*-DAPDHs with NADH preference for the production of D-amino acids.
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ijms-21-01788-t001_Table 1

###### 

Kinetic parameters of wild-type and mutant StDAPDH with pyruvic acid as the substrate

  Enzyme         K~M~ (mM)     *k*~cat~ (s^--1^)   *k*~cat~/K~M~ (mM^-1^·s^--1^)   Cofactor
  -------------- ------------- ------------------- ------------------------------- ----------
  StDAPDH        ND ^1^        ND                  ND                              NADH
  8.86 ± 0.45    7.61 ± 0.18   0.86                NADPH ^2^                       
  V14L           ND            ND                  ND                              NADH
  10.08 ± 0.96   1.63 ± 0.08   0.16                NADPH ^2^                       
  K159R          8.04 ± 0.85   1.34 ± 0.20         0.17                            NADH
  7.58 ± 0.45    8.07 ± 0.21   1.06                NADPH ^2^                       

^1^ Not detectable. ^2^ Data from our previous study \[[@B30-ijms-21-01788]\].

[^1]: These authors contributed equally to this work.
